Develops diagnostic test kits for foodborne pathogens and animal safety.
Aug 2026Revenue $884M/yrExpenses $891M/yr
Fell below break-even Sep 2024
Figures by year
When will Neogen be profitable again?
Its expenses passed its revenue in Sep 2024. In the 12 months to Aug 2026, revenue was $884M and expenses $891M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| May 2026 | $870M | $892M | −$21.6M |
| May 2025 | $895M | $1.96B | −$1.06B |
| May 2024 | $924M | $866M | $58.6M |
| May 2023 | $822M | $785M | $37.5M |
| May 2022 | $527M | $469M | $58.6M |
| May 2021 | $468M | $394M | $74.2M |
| May 2020 | $418M | $351M | $67.5M |
| May 2019 | $414M | $346M | $68.1M |
| May 2018 | $398M | $328M | $70.2M |
| May 2017 | $358M | $293M | $64.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.